Cisplatin

3:39
KEYNOTE-966: pembrolizumab, gemcitabine and cisplatin for CCA
Arndt Vogel
5:59
Perioperative genotype-dosed gFOLFIRINOX with margin-negative resection in gastroesophageal cancer
Daniel Catenacci
2:33
Localized anal cancer in patients with HIV
Rachel Riechelmann
4:28
PROOF: infigratinib as first-line therapy in patients with advanced CCA
Ghassan Abou-Alfa
1:45
PROOF 301: infigratinib in advanced CCA
Milind Javle
2:03
Thoughts on the RAMES study in mesothelioma
Sanjay Popat
1:08
Chemotherapy-induced peripheral neuropathy
Cynthia X. Ma
3:04
Irinotecan/cisplatin vs etoposide/cisplatin in resected high-grade neuroendocrine lung carcinoma
Hirotsugu Kenmotsu
2:06
CheckMate-743 study in mesothelioma
Dean Fennell
4:24
SWOG S1416: cisplatin +/- veliparib in TNBC
Priyanka Sharma
2:54
Risk stratification in metastatic seminoma
Peter Albers
7:53
Growing treatment landscape for advanced bladder cancer
Cora Sternberg
4:44
NEO-BLADE trial: nintedanib and chemotherapy in bladder cancer
Syed Hussain
1:53
Alison Birtle: ASCO GU highlights
Alison Birtle
01:12
Chemo eligibility: bladder cancer
Srikala Sridhar
1:09
ENERGIZE: chemo + nivo with/without linrod for bladder cancer
Guru Sonpavde
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals